Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05386355 · ClinicalTrials.gov registry record · NA
Improving Pediatric COVID-19 Vaccine Uptake Using an mHealth Tool
A NA study, sponsored by IDeA States Pediatric Clinical Trials Network.
- Completed
- Registry status
- NA
- Development phase
- 1,934
- Enrollment target
NCT05386355: Completed NA study, sponsored by IDeA States Pediatric Clinical Trials Network.
NCT05386355 is a NA study that has completed, run by IDeA States Pediatric Clinical Trials Network. The registered enrollment target is 1,934 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (38% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05386355, a NA study, has completed, sponsored by IDeA States Pediatric Clinical Trials Network.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,934 participants
- Enrollment target
Study Summary
This study will determine the effectiveness of a vaccine communication mobile health app on parental decisions to vaccinate their children against coronavirus disease 2019 (COVID-19). The hypothesis is that unvaccinated children of caregivers assigned to the Vaccine Uptake app will be more likely to achieve COVID-19 vaccine series completion than those children whose caregivers are assigned to the General Health app.
Primary Outcome
Initiation and completion of the COVID-19 vaccine series during the 24-week intervention period. Vaccine series completion will be per ACIP guidance for the vaccine product. For children who receive a product that requires more than 2 doses for the primary series, receipt of up to 3 doses will be considered complete. Vaccine doses will be valid if given within 24-week study intervention. Additional doses for primary series completion will be valid if they are in accordance with ACIP-recommended
Interventions
- BEHAVIORAL COVID-19 Vaccine Uptake App
- OTHER General Health App
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,934 participants |
| Start Date | 2022-07-18 |
| Est. Completion | 2023-09-25 |
| Phase | NA |
What the finished NCT05386355 record still lists
NCT05386355 is an interventional study that assigns participants to a tested intervention. Its 1,934 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (38% higher).
The record links to 0 conditions, and to 2 interventions - of which COVID-19 Vaccine Uptake App is the first listed.
NCT05386355 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05386355 about?
NCT05386355 is a clinical study titled "Improving Pediatric COVID-19 Vaccine Uptake Using an mHealth Tool". This study will determine the effectiveness of a vaccine communication mobile health app on parental decisions to vaccinate their children against coronavirus disease 2019 (COVID-19). The hypothesis is that unvaccinated children of caregivers assigned to the Vaccine Uptake app will be more likely t...
What is the current status of trial NCT05386355?
This trial is currently completed. It is a NA study. The enrollment target is 1,934 participants. The study started on 2022-07-18. Estimated completion is 2023-09-25.
What interventions are being tested in trial NCT05386355?
The interventions under investigation include: COVID-19 Vaccine Uptake App (BEHAVIORAL), General Health App (OTHER).
Who is sponsoring clinical trial NCT05386355?
This trial is sponsored by IDeA States Pediatric Clinical Trials Network, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05386355's enrollment target sits among peer trials
1,934 55th of 2000 higher than 1,946 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05233150 · 1,932 participants · NA
Child-Adult Relationship Enhancement in Primary Care (PriCARE) / Criando Niños Con CARIÑO (CARIÑO)
- NCT06058455 · 1,920 participants · NA
An Evaluation of an Online Sexual Assault Resistance Program (IDEA3)
- NCT04251052 · 1,956 participants · NA
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
- NCT05174169 · 1,912 participants · Phase 2
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI